Quadrant Capital Group LLC Bio Techne Corp Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,458 shares of TECH stock, worth $105,763. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,458

Previous 1,461 0.21%

Holding current value

$105,763

Previous $104,000 11.54%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$70.96 - $82.35 $212 - $247	-3 Reduced 0.21%	1,458 $116,000
Q2 2024 Aug 12, 2024	BUY	$62.12 - $84.15 $2,360 - $3,197	38 Added 2.67%	1,461 $104,000
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $19,991 - $23,358	303 Added 27.05%	1,423 $100,000
Q4 2023 Feb 08, 2024	BUY	$52.83 - $78.22 $17,064 - $25,265	323 Added 40.53%	1,120 $86,000
Q3 2023 Nov 14, 2023	SELL	$67.52 - $89.42 $31,329 - $41,490	-464 Reduced 36.8%	797 $54,000
Q2 2023 Aug 09, 2023	SELL	$73.76 - $85.98 $4,646 - $5,416	-63 Reduced 4.76%	1,261 $102,000
Q1 2023 May 11, 2023	SELL	$71.62 - $86.62 $16,615 - $20,095	-232 Reduced 14.91%	1,324 $98,000
Q4 2022 Feb 10, 2023	BUY	$80.67 - $352.29 $91,318 - $398,792	1,132 Added 266.98%	1,556 $128,000
Q3 2022 Nov 10, 2022	BUY	$282.54 - $391.85 $26,276 - $36,442	93 Added 28.1%	424 $120,000
Q2 2022 Aug 09, 2022	SELL	$322.67 - $449.65 $10,325 - $14,388	-32 Reduced 8.82%	331 $115,000
Q1 2022 May 06, 2022	BUY	$353.85 - $487.79 $13,800 - $19,023	39 Added 12.04%	363 $157,000
Q4 2021 Feb 01, 2022	BUY	$456.15 - $525.06 $42,421 - $48,830	93 Added 40.26%	324 $168,000
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $12,901 - $15,627	29 Added 14.36%	231 $112,000
Q2 2021 Aug 09, 2021	SELL	$387.35 - $450.26 $6,972 - $8,104	-18 Reduced 8.18%	202 $91,000
Q1 2021 May 12, 2021	BUY	$314.62 - $411.0 $7,236 - $9,453	23 Added 11.68%	220 $84,000
Q4 2020 Feb 16, 2021	BUY	$246.9 - $321.87 $987 - $1,287	4 Added 2.07%	197 $63,000
Q3 2020 Nov 13, 2020	SELL	$232.22 - $282.96 $78,258 - $95,357	-337 Reduced 63.58%	193 $48,000
Q2 2020 Aug 13, 2020	BUY	$185.43 - $279.56 $55,814 - $84,147	301 Added 131.44%	530 $140,000
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $29,332 - $40,314	182 Added 387.23%	229 $43,000
Q3 2019 Oct 24, 2019	SELL	$183.56 - $216.72 $43,320 - $51,145	-236 Reduced 83.39%	47 $8,000
Q1 2019 Apr 29, 2019	BUY	$136.09 - $200.44 $32,117 - $47,303	236 Added 502.13%	283 $54,000
Q4 2017 Jan 31, 2018	SELL	$121.17 - $134.75 $8,360 - $9,297	-69 Reduced 59.48%	47 $5,000
Q3 2017 Oct 13, 2017	BUY	$113.59 - $123.78 $1,817 - $1,980	16 Added 16.0%	116 $12,000
Q2 2017 Aug 15, 2017	BUY	N/A	100	100 $10,000

Others Institutions Holding TECH

# of Institutions

604

Shares Held

151M

Call Options Held

179K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.85B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Bio Techne Corp Transaction History